CLINICAL_TRIALS
withdrawal
· 2015-10-26
Clinical Trial Update: UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies [Phase 1]
Summary
A phase 1 clinical trial (UARK 2006-28) of human cord blood transplantation in advanced hematological malignancies has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 1 | Status: WITHDRAWN